Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia
Clinical trial NCT04106076 · WITHDRAWN
Trial details
- NCT number
- NCT04106076
- Sponsor
- Cellectis S.A.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-11
- Primary completion
- 2019-12-05
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.